This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
Hang on a second…

This CME Activity has expired and is no longer available for credit.

A 75-Year-Old Woman With Complaints of Forgetfulness

A 75-Year-Old Woman With Complaints of Forgetfulness


Patient Case Study

Time to Complete

30 minutes


August 28, 2015


December 31, 2016
Add to Queue

Maximum Credits

0.50 / AMA PRA Category 1 CreditTM

Accredited Provider

This activity is provided by Albert Einstein College of Medicine of Yeshiva University in collaboration with Haymarket Medical Education (HME).

Commercial Supporter

This activity is supported by an educational grant from Lilly.

Program Description

An older patient who complains of occasional forgetfulness but is otherwise able to function normally may be an example of the “worried well” or may in fact be in an early stage of Alzheimer’s disease (AD). Current research suggests that early intervention aimed at slowing symptom progression may be more successful than later attempts to treat individuals who are already experiencing more significant cognitive deficits.

Intended Audience

Neurologists and other healthcare professionals who provide care for patients with or at risk for AD and related dementias

Educational Objectives

After participating in this activity, practitioners should be better able to:

  • Identify the clinical relevance of ongoing research on treatment approaches to AD
  • Initiate measures intended to delay or slow the progression of AD in patients who may be at risk or are exhibiting signs suggesting early disease
  • Identify resources and strategies to provide a continuum of care for patients and their caregivers while patients are in the early stages of, or at risk for, AD

Conflict Of Interest Disclosure Policy

It is the policy of Albert Einstein College of Medicine of Yeshiva University to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty participating in our programs are expected to disclose any relationships they may have with commercial companies whose products or services may be mentioned, so that participants may evaluate the objectivity of the presentations. In addition, any discussion of off-label, experimental, or investigational uses of drugs or devices will be disclosed by the faculty.


Course Director
Victor B. Hatcher, PhD

Professor of Medicine and Biochemistry
Montefiore Medical Center
Bronx, NY

Dr. Hatcher has nothing to disclose.

Peer Reviewer
Gary Kennedy, MD

Professor of Psychiatry
Montefiore Medical Center
Bronx, NY

Dr. Kennedy has received grant/research support from Lilly.

Bradford C. Dickerson, MD

Associate Professor of Neurology
Harvard Medical School
Director of Clinical Applications, Morphometry Service
Director, Frontotemporal Disorders Unit
Massachusetts General Hospital
Co-Director, Neuroimaging Group, Gerontology Research Unit
Boston, MA

Dr. Dickerson received royalties from Oxford University Press for the book Dementia: Comprehensive Care and Practice, and he is a consultant to Merck, FORUM Pharmaceuticals, and Isis Pharmaceuticals.

Martin R. Farlow, MD
Professor and Vice Chairman of Research
Department of Neurology
Associate Director
Indiana Alzheimer Disease Center
Indiana University School of Medicine
Indianapolis, IN

Dr. Farlow serves as a consultant for Accera, Alltech, Avanir, Biogen, Eisai Medical Research, Inc., Eli Lilly, FORUM Pharmaceuticals, GliaCure, Grifols, Helicon, INC Research, Lundbeck, MedAvante, Medivation, Inc., Merck & Co., Inc., Novartis, Pfizer, Prana Biotechnology, QR Pharma, Roche, Sanofi-Aventis, Schering-Plough, Taisho Toyama Pharmaceutical Co., Takeda, and UCB. He also serves on the speakers’ bureaus for Eisai, Eli Lilly, Forest, Pfizer, and Novartis and has received grant/research support from Accera, Biogen, Chase Pharmaceuticals, Eisai, Eli Lilly, Genentech, Lundbeck, and Roche. Dr. Farlow has a patent that is licensed to Elan.

Accredited Provider Disclosure

The staff of the Center for Continuing Medical Education of Albert Einstein College of Medicine of Yeshiva University has no disclosures to report with any commercial interests relative to this CME activity.

Planners' and Managers' Disclosures

Jill Rovitzky Black, Margot Embree Fisher, and Sarah Taegder of Haymarket Medical Education have nothing to disclose with regard to commercial support.




AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Albert Einstein College of Medicine of Yeshiva University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

Albert Einstein College of Medicine of Yeshiva University designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Lilly, Albert Einstein College of Medicine of Yeshiva University, and Haymarket Medical Education do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Eli Lilly, Albert Einstein College of Medicine of Yeshiva University, or Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


To obtain credit, a score of 70% or better is required. This CME is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on within your Profile/CME History, which you can then access at any time.


Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue